A total of 100 patients with bilateral established macular scarring resulting from subretinal neovascularisation in age-related macular degeneration were identified. Of these, 19 patients were not included owing to inadequate follow-up, leaving a study population of 81 patients.
Interobserver agreement error was tested with a random series of 10 eyes. Figure 3 . In 38-8% (14/36) offellow eyes, scars measured less than 0-5x 106 Vim2, and 61-1%
were less than lx106 pm2 in area. Only 16-7% (6/36) had large scar sizes (>3 x 106 1Im2).
Scars measuring 3X 106 jIm2 or more in area were identified in 42 eyes of 28 patients. The distribution of scar sizes in the fellow eye of patients with one scar measuring 3 x 106 pin2 or more is charted in Figure 3 . In 21-4% (6/28) the scar in the fellow eye measured less than 0-5x 106 PMi2, and in 28-6% (8/28) measured less than lx 106 ,m'. In 50% (14/28) the fellow eye scar was 3 or more x 106 tLm' in area.
We compared the distribution of scar sizes in fellow eyes of eyes with small scars (<0-S x 106 jim2) with that of fellow eyes of eyes with large scars (>3-Ox 106 Im'2). The data summarised in []=Fellow eye ofsmall scar. =Fellow eye oflarge scar.
with the XI test (X'=20-07,2 degrees of freedom, p<O-OOl). Figure 4 demonstrates that a correlation exists between the scar size in one eye and the scar size in the fellow eye. Although a number of outliers exist, a clear uptrend is present (r=0-53, p<0-001; 95% confidence level for correlation coefficient: 0-37-0-77).
We also assessed the degree of concordance of scar size using the x statistic.' This produced a weighted x score of 0-547 (standard error= 0-153), indicating a degree of concordance rated as 'fair to good'. '6 We examined the scar sizes in 20 pairs of eyes with a minimum of six months' follow-up, and compared them with a group of 18 eyes with a minimum of three years' follow-up. There was no significant difference in the distribution of scar sizes between the two groups (p=0-36). We were concerned that eyes with a shorter duration of follow-up might have had evolving lesions which had not yet reached their final scar size. We re-examined the question of concordance of scar size for 43 patients with a minimum follow- Right area scar (A2 ) Figure 4 Area ofscar: right and left eyes ofpairs compared. Numbers on chart refer to number ofpairs ofeyes located at similar points. Line ofbestfit has been added (r=0-53, p<0-001; 95% confidence levelfor correlation coefficient: 0-37-0-77). In a review of a sequential series of patients with SRNVM formation secondary to AMD, the majority had scar sizes larger than one disc diameter (68%).9 It is interesting to note a biphasic distribution ofscar size in the study (Fig  2) . This biphasic peak suggests that different factors determine whether an eye develops either a small or a large scar. Such an 'on or off' response is compatible with several types of cellular phenomena, and may be the end result of a retinal environment inhibitory to or stimulating SRNVM formation. In this light it is interesting to note that the retinal pigment epithelium may have a major role in regulating the activity of laser induced experimental SRNVMs24 and of vascular endothelial cells.28
Some evidence suggests that inflammatory and immunocompetent cells may play a part in the genesis of both the atrophic forms of AMD29 and its neovascular complications.n0 Immunological responses vary markedly between individuals, and can effect damping or recruitment -that is, 'on or off responses. It is possible that factors such as these may explain in part the marked variation between individuals in final scar size, the close symmetry between eyes, and the bimodal distribution of scar sizes found in this study.
We considered whether our results could have been the result of biased case collection. We included all sequential patients who fulfilled the entry criteria, but the high mortality in this age group meant that a number of patients could not be included owing to inadequate follow-up. However, we found no obvious differences in the initial photographs of those patients with inadequate follow-up compared with those entered in this study. It is possible that the high peak in the group with large scars may represent patients with severe disease who attend frequently for visual aid; however, we found no difference in follow-up between the small scar and large scar groups.
In summary, we have found that eyes with a large macular scar resulting from age-related SRNVM formation have a high probability of developing a large scar if SRNVM forms in the remaining eye. This has implications for the management of patients and for the design of clinical trials.
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